SARS-CoV-2 mRNA vaccine induced higher antibody affinity and IgG titers against variants of concern in post-partum vs non-post-partum women

Affiliations

• ¹ Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), 10903 New Hampshire Avenue, Silver Spring, MD 20871, USA.
• ² Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA.
• ³ Division of Pulmonary and Critical Care, Department of Internal Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
• ⁴ Department of Pharmacy, University of Maryland Medical Center, Baltimore, MD, USA.
• ⁵ Division of Infectious Disease, Department of Internal Medicine, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD USA.
• ⁶ University of Maryland School of Medicine, Baltimore, MD USA.
• ⁷ University of Maryland Medical Center, Baltimore, MD USA.
• ⁸ Department of Obstetrics and Gynecology, University of Maryland School of Medicine, Baltimore, MD, USA.
• ⁹ Department of Medicine, Program in Trauma, University of Maryland School of Medicine, Baltimore, MD, USA.
• ¹⁰ Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
• ¹¹ Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD USA.
• ¹² Department of Medicine, Baltimore VA Medical Center, Baltimore, MD 21201, USA.
• ¹³ National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD USA.
• ¹⁴ Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), 10903 New Hampshire Avenue, Silver Spring, MD 20871, USA. Electronic address: [email protected].